PPARGC1A and infection: PCR analysis revealed ZLN005 treatment resulted in a significant increase in PGC-1α mRNA (ppargc1a) compared to control, and attenuated MAC-mediated decreases during 6-hour infection (Fig 2A) and 24-hour infection (Fig 2B).